Frank Tagliaferri, Ph.D. Featured in Panel Session on Advancing Oral Drug Delivery Beyond Lipinski’s Rule of 5
Chief Scientific Officer of Pace® Life Sciences Joins Industry Leaders at Advancing Drug Development Forum (ADDF) to Collaborate on Technologies for Non-Traditional Molecules BOSTON, MA – December 5, 2025 – Pace® Life Sciences, a U.S.-based CRDMO and FDA-registered GMP Analytical Testing lab, announced that Chief Scientific Officer Frank Tagliaferri, Ph.D., will join a round table […]









